Abstract
Nurse PrescribingVol. 11, No. 1 Calculation SkillsCalculation skills: AnswersSharon ReesSharon ReesSearch for more papers by this authorSharon ReesPublished Online:16 Aug 2013https://doi.org/10.12968/npre.2013.11.1.38AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References AbbVie Limited (2012) SPC: Chirocaine 2.5mg/ml solution for injection/concentrate for solution for infusion. Updated 25 January 2012. www.medicines.org.uk/EMC/medicine/8010/SPC/Chirocaine+2.5mg+ml+solution+for+injection+concentrate+for+solution+for+infusion Google ScholarAccord Healthcare Limited (2012a) SPC: Lidocaine 1% w/v solution for injection. Updated 24 May 2012. www.medicines.org.uk/EMC/medicine/26502/SPC/Lidocaine+1++w+v+solution+for+injection Google ScholarAccord Healthcare Limited (2012b) SPC: Bupivacaine 0.5% w/v solution for injection. Updated 24 May 2012. www.medicines.org.uk/EMC/medicine/26508/SPC/Bupivacaine+0.5++w+v+solution+for+injection Google ScholarAnaesthesia UK (2009) Pharmacology of regional anaesthesia. www.frca.co.uk/article.aspx?articleid=100816 Google ScholarAstraZeneca UK Limited (2012a) SPC: Xylocaine 1% and 2% with Adrenaline. Updated 20 November 2012. www.medicines.org.uk/EMC/medicine/17526/SPC/Xylocaine+1++and+2++with+Adrenaline Google ScholarAstraZeneca UK Limited (2012b) SPC: Citanest 1%. Updated 26 September 2012. www.medicines.org.uk/EMC/medicine/163/SPC/Citanest+1 Google ScholarAstraZeneca UK Limited (2012c) SPC: Naropin 2 mg/ml solution for injection. Updated 2 May 2012. www.medicines.org.uk/EMC/medicine/7286/SPC/Naropin+2+mg+ml++solution+for+injection Google ScholarCox B, Durieux ME, Marcus MA (2003) Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol 17(1): 111–36 Crossref, Google ScholarEdgcombe H, Hocking G (2006) Local anaesthetic pharmacology. www.frca.co.uk/article.aspx?articleid=100505 Google ScholarFaccenda KA, Finucane BT (2001) Complications of regional anaesthesia Incidence and prevention. Drug Saf 24(6): 413–42 Crossref, Google ScholarJoint Formulary Committee (2012a) British National Formulary 64. British Medical Association and Royal Pharmaceutical Society of Great Britain, London Google ScholarJoint Formulary Committee (2012b) British National Formulary for Children 2012–2013. British Medical Association and Royal Pharmaceutical Society of Great Britain, London Google ScholarMercury Pharma Group (2012) SPC: Bupivacaine & Adrenaline Injection BP 0.5% w/v, 1 in 200,000. Updated 11 October 2012. www.medicines.org.uk/EMC/medicine/22178/SPC/Bupivacaine+%26+Adrenaline+Injection+BP+0.5++w+v%2c+1+in+200%2c000 Google ScholarRajan N (2010) Management of severe local anesthetic toxicity. In: The Association of Anaesthetists of Great Britain and Ireland (2009) AAGBI Safety Guidelines: 76–79. http://update.anaesthesiologists.org/wp-content/uploads/2009/12/Management-of-local-anaesthetic-toxicity.pdf Google ScholarTuckley JM (1994) Pharmacology of local anaesthetic agents. www.nda.ox.ac.uk/wfsa/html/u04/u04_014.htm Google Scholar FiguresReferencesRelatedDetails 1 January 2013Volume 11Issue 1ISSN (print): 1479-9189ISSN (online): 2052-2924 Metrics History Published online 16 August 2013 Published in print 1 January 2013 Information© MA Healthcare LimitedPDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
